Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

计划入组 35 人 · 首次发布于 2023 年 8 月 14 日

Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets

计划入组 24 人 · 首次发布于 2009 年 3 月 2 日

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

计划入组 32 人 · 首次发布于 2014 年 7 月 10 日

Eylea Biosimilar(Alteogen, Inc.)

Aflibercept(Eylea, Zaltrap, Yesafili, Eydenzelt, Ahzantive, Afqlir, Baiama, Opuviz, Pavblu, Mynzepli, Vgenfli, Eiyzey)

Rx

Aflibercept/Rinucumab

DAS-MG, Inc

Hut 8 Corp

Canada

Mistras Group

United States

EMA Approves Pre-filled Syringe for Eylea 8 mg, Enhancing AMD and DME Treatment

Eylea HD Shows Promise in Macular Edema Following Retinal Vein Occlusion

Alvotech Challenges Regeneron's High-Dose Aflibercept Patent in Post-Grant Review